Volitionrx (VNRX) Income from Non-Controlling Interests (2020 - 2025)
Volitionrx posted quarterly Income from Non-Controlling Interests of -$52868.0 for Q1 2025, up 49.47% year-on-year from -$35371.4 in Q1 2024, and up 17.2% on a QoQ basis from -$63854.0 in Q4 2024.
Volitionrx (VNRX) has 5 years of Income from Non-Controlling Interests data on file, last reported at -$52868.0 in Q1 2025.
- For the quarter ending Q1 2025, Income from Non-Controlling Interests rose 49.47% year-over-year to -$52868.0; the trailing twelve-month figure through Mar 2025 stood at -$89142.0 (up 57.28% YoY), and the FY2024 full-year result was -$290149.0, up 18.95% from the prior year.
- Income from Non-Controlling Interests for Q1 2025 stood at -$52868.0, up from -$63854.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $93361.0 in Q1 2023 and bottomed at -$104617.0 in Q1 2024.
- The 4-year median for Income from Non-Controlling Interests is -$52868.0 (2025), against an average of -$18737.5.
- The widest annual swing landed in 2023, when Income from Non-Controlling Interests jumped 211.17%; it then tumbled 212.06% in 2024.
- A 4-year view of Income from Non-Controlling Interests shows it stood at $82302.0 in 2022, then slumped by 223.27% to -$101450.0 in 2023, then surged by 37.06% to -$63854.0 in 2024, then advanced by 17.2% to -$52868.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at -$52868.0 (Q1 2025), -$63854.0 (Q4 2024), and -$47049.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -52,868.00 |
| Dec 31, 2024 | -63,854.00 |
| Sep 30, 2024 | -47,049.00 |
| Jun 30, 2024 | 74,629.00 |
| Mar 31, 2024 | -104,617.00 |
| Dec 31, 2023 | -101,450.00 |
| Sep 30, 2023 | -82,887.00 |
| Jun 30, 2023 | 80,298.00 |
| Mar 31, 2023 | 93,361.00 |
| Jun 30, 2022 | 82,302.00 |
| Mar 31, 2022 | -83,977.00 |
| Sep 30, 2020 | 8,050.00 |
| Jun 30, 2020 | 5,779.00 |
| Mar 31, 2020 | 9,567.00 |